Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Candesartan for Prophylaxis of Episodic Cluster Headache
NCT00184587Phase 2Completed
- Sponsor
- Norwegian University of Science and Technology
- Start
- Mar 2005
- Primary completion
- Jun 2009
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of candesartan cilexetil in Cluster Headache (CH), sponsored by Norwegian University of Science and Technology. Started Mar 2005; status: completed.
02
Drugs
candesartan cilexetil
03
Conditions
Cluster Headache (CH)
Beyond the preview
Go deeper on NCT00184587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00184587.